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Abstract 
Paraquat (PQ) is a commonly used herbicide that induces oxidative stress via reactive oxygen species (ROS) 
generation. This study aimed to investigate the effects of the antioxidant N-acetylcysteine (NAC) against PQ-
induced oxidative stress in mice. Male Balb/C mice (24) were randomly divided into 4 groups and treated for 3 
weeks: 1) control (saline), 2) NAC (0.5% in diet), 3) PQ (20 mg/kg, IP) and 4) combination (PQ + NAC). 
Afterwards mice were sacrificed and oxidative stress markers were analyzed. Our data showed no significant 
change in serum antioxidant capacity.  
 
------------------------------------------------------------------------ 
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PQ enhanced lipid peroxidation (MDA) levels in liver tissue compared to control whereas NAC decreased 
MDA levels (p<0.05). NAC significantly increased MDA in brain tissue (p<0.05). PQ significantly depleted 
glutathione (GSH) levels in liver (p=0.001) and brain tissue (p<0.05) but non-significant GSH depletion in lung 
tissue. NAC counteracted PQ, showing a moderate increase GSH levels in liver and brain tissues. PQ 
significantly increased 8-oxodeoxyguanosine (8-OH-dG) levels (p<0.05) in liver tissue compared to control 
without a significant change in brain tissue. NAC treatment ameliorated PQ-induced oxidative DNA damage in 
the liver tissue. PQ significantly decreased the relative mtDNA amplification and increased the frequency of 
lesions in liver and brain tissue (p<0.0001), while NAC restored the DNA polymerase activity in liver tissue but 
not in brain tissue. In conclusion, PQ induced lipid peroxidation, oxidative nuclear DNA and mtDNA damage in 
liver tissues and depleted liver and brain GSH levels. NAC supplementation ameliorated the PQ-induced 
oxidative stress response in liver tissue of mice. 
Keywords: Antioxidant Capacity; DNA Integrity; Glutathione levels; MDA levels; Mice; Oxidative Stress; 
Reactive Oxygen Species. 
1. Introduction  
Oxidative stress occurs when the dynamics of reduction and oxidation (REDOX) balance between oxidants and 
antioxidants is shifted towards oxidant potentials [71]. Oxidative stress-related diseases include psoriasis, renal 
graft, retinal damage, atherosclerosis, asthma, Parkinson’s disease and multi-organ diseases such as diabetes and 
cancer [79]. An overwhelm number of studies converge that the mitochondria plays an important role on the 
onset and development of the aforementioned pathologies [35]. 
The mitochondria unlike other organelles, contains its own genome, mitochondria DNA (mtDNA) and is the 
largest supplier of ATP and the main source of reactive oxygen species (ROS) in aerobic organisms  [10, 51].   
Due to the electron transport chain (ETC) in the inner mitochondrial membrane, there is a high endogenous 
ROS production that disrupts the homeostasis, cell signaling and also leads to mitochondrial genome instability 
[23]. A compromised ETC increases the ROS levels introducing damage in lipids, DNA, and perturbs both the 
glutathione scavenging and antioxidant capacity [34]. Cells are constantly challenged by exogenous stressors 
from environmental conditions such as chemicals, drugs, and UV light exposure as well as by endogenous 
stressors including ROS and quinones.  The repetitive exposure to environmental agents such as 
pesticides/herbicides exacerbates the generation of ROS, and down regulates the levels of antioxidant defenses. 
For example, Paraquat (PQ; 1,1-dimethyl-4,4-bipyridium dichloride), is a redox cycling compound that  
selectively produce ROS by uncoupling the ETC complex in the mitochondria [15]. This causes an increase in 
the intracellular oxidative microenvironment leading to the decline in the supply of cellular energy, inducing 
cell death, and depleting glutathione (GSH) [18, 40]. 
The mechanism of action of PQ toxicity consists in the generation of superoxide anions, which leads to the 
proliferation of ROS and the oxidation of NADPH, a major source of reducing equivalents required in 
biosynthetic processes [76]. ROS interferes with NADPH electron shuttling by diminishing the pool of available 
NADP+, whom itself is needed for the progression of metabolic REDOX reactions.  The main organ affected by 
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PQ are the lungs, in which the oxidant agent is transported in the Clara cells and alveolar type I and II epithelial 
cells, leading to a second proliferating phase defined by alveolitis and pulmonary edema [12]. Trace amounts of 
PQ can be detected in more than 100 crops (corn, tomatoes, olives, field beans, fruits) highlighting the need to 
study the effects of PQ that may be affecting the public health of the general population whom often 
misinformed on the proper use of PQ [61, 62]. PQ effects in rodent models showed that prolonged exposure 
leads to accumulation and persistent damage in brain lung and liver tissues providing insight of a better 
understanding of PQ actions [15, 17, 39, 40, 61, 62, 78]. 
N-acetylcysteine (NAC) is an oral supplement that have demonstrated high efficacy acting as a reducing agent. 
NAC is considered a cost-effective and approved therapy with a forty-year safety history towards a number of 
illnesses such as neurocognitive disorders, liver toxicity, heavy metal toxicity, acute respiratory syndrome, and 
chemotherapy induced toxicity [9, 63, 83]. NAC is the acetylated precursor of L-cysteine, who itself is a 
precursor of glutathione (GSH). NAC acts as an electron acceptor, preventing oxidative damage and increasing 
intracellular glutathione biosynthesis, which is a key component in the preservation of a positive REDOX 
potential [27]. NAC can permeate the cell membrane under physiological conditions [58,67]. According to 
previous studies, NAC crosses the Blood Brain Barrier (BBB) through deacetylation pathways and is capable of 
being actively transported through cysteine carrier mediated mechanism in kidneys, liver, adrenal glands, lungs, 
and brain tissues [73, 75]. Small molecules as NAC can diffuse across the cell membrane when the membrane 
loses its stability as a consequence of oxidative stress damage [43]. 
In vivo studies, showed the ability of NAC to penetrate the BBB by crossing the capillary wall and reaching 
brain tissues and extracellular space using radiolabeled NAC in a SAMP8 mice model [28]. NAC can stabilize 
to the mitochondria ETC acting upon the complexes I and IV of liver and brain mice tissue [19, 54].  In vitro 
studies showed that NAC supplementation preserved and protected the inner mitochondrial membrane leading 
to a greater amount of ATP production and decreasing ROS levels [5, 6, 33]. In lung tissue, NAC has been used 
as a therapeutic mucolytic agent providing protection in the surfactant surrounding the alveolar tissue by 
avoiding GSH depletion [31]. 
The present study was undertaken in order to investigate the antioxidant effects of NAC to afford protection in 
mice vital tissues that have been exposed to a well-known ROS generator, as PQ. Our central hypothesis stated 
that NAC reduces oxidative stress induced by PQ in liver, brain, and lung mice tissues.   
2. Materials and Methods 
2.1 Reagents  
Paraquat dichloride and N-Acetylcysteine (NAC) were purchased from Sigma-Aldrich.  Dulbecco's Phosphate-
Buffered Saline (DPBS) was purchased from Life Technologies. Colorimetric assay kits were purchased from 
Cayman chemicals. 8-oxodeoxyguanosine was measured using the Oxiselect TM Oxidative DNA damage ELISA 
(Cell Biolab). PCR studies were performed with the GeneAmp High Fidelity PCR system (Applied Biosystems) 
and Quant-iT PicoGreen® dsDNA Assay Kit (Invitrogen). 
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2.2 Oxidative Stress Animal Model 
Balb/C male mice (6-7 months old, weighing approximately 24-32g) were keep in a temperature-controlled 
room on a 12:12 hrs light:dark schedule with regular chow and water ad libitum. The food intake and the body 
weight of the animals were recorded weekly. The Institutional Animal Care and Use Committee (IACUC) 
approved all procedures in accordance with the Animal Welfare Assurance A3585-01. 
2.3 Drug schedule and administration 
N-Acetylcysteine (NAC) was administered in the form of supplemented rodent chow at 0.5% and DPBS saline 
buffer (1X) was used for sham treatments and as a vehicle for Paraquat treatment. The four experimental groups 
were as followed: Control (sham ip injections and regular chow), NAC (sham ip injections and supplemented 
chow), PQ (20 mg/kg ip injections of Paraquat and regular chow) PQ+NAC (20 mg/kg ip injections of Paraquat 
and supplemented chow). During a 3-week period, mice were given the aforementioned injections twice a week. 
All groups received their appropriate treatments simultaneously and at same time points.  
2.4 Tissue and blood collection 
Liver, brain and lung tissues were collected and cryopreserved using liquid nitrogen and stored at -80°C. The 
tissues were prepared individually accordingly to the manufacturer's specifications for each assay. Mice were 
anesthetized using isoflurane (Sigma). Between 200-350µL of whole blood was extracted via heart-puncture 
using a 22G x 1.5 inches BD 3mL Syringe needle (Terumo, Co) and stored in 1.5mL collection tubes (non-
anticoagulant tubes). Blood was allowed to clot for 30 min at 25ºC and centrifuged at 2,000 x g for 15 min at 
4ºC. The top yellow serum was collected and stored on ice to avoid hemolysis.  
2.4.1 Tissue homogenization for lipid peroxidation and total glutathione analysis 
Liver, brain and lung tissues were homogenized manually using a TissueMiser (Fisher Scientific) in a solution 
of 1x PBS with EDTA (1mM, pH 7.4) over ice. According to the tissue weight, a total of 1 mL of PBS with 
EDTA solution was added to brain and liver tissues and a total of 250µL of PBS with EDTA was added to the 
lung tissue. The homogenates were centrifuged at 10,000 x g for 15 min at 4°C. The supernatant obtained were 
transferred to 0.5 mL microtubes and stored at -20°C. Lastly, supernatant volumes were aliquoted and equally 
divided further for lipid peroxidation and total glutathione analysis. 
2.4.2 Tissue homogenization for mtDNA analysis 
Frozen liver and brain tissues were homogenized with a Bullet Blender Machine (Next Advance, Inc.). The 
brain tissue samples were homogenized by the pink bead lysis/0.5 mm glass beads and the hepatic tissue 
samples were homogenized with green bead lysis/0.5 mm zirconium oxide beads. Homogenized tissues were 
lysed with Buffer G2 (Qiagen, Valencia). 
2.5 Oxidative stress analysis 
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2.5.1 Antioxidant Capacity test 
To evaluate the antioxidant capacity of serum we used an Antioxidant Assay Kit that relies on the ability of 
antioxidants in a sample to inhibit the oxidation of ABTS (2,2’-Azino-di-(3-ethylbenzthiazoline sulphonate) to 
ABTS+ by metmyoglobin. The serum samples were diluted 1:20 and absorbance was read at 405 nm using 
Dynex spectrophotometer (Life technologies). The assay was done at duplicates and the results were showed as 
the antioxidant capacity (mM), in terms of Trolox equivalents. 
2.5.2 Glutathione (GSH) assay 
Glutathione levels in liver, brain and lung tissues were measured using a Glutathione Assay Kit. These samples 
were deprotinated according to the manufacture’s recommendations, assayed in triplicates and analyzed at 405 
nm using a Thermo Multiskan spectrophotometer microplate reader. The results were expressed as the total 
GSH levels (µM)/g of tissue. Individualized dilution factors were performed for liver tissue (1:50 dilution 
factor) and lung tissue (1:1, 1:2, 1:3, 1:3.5 dilution factors), whereas for brain tissue, undiluted sample were 
used. Samples were stored at -20°C until further use for glutathione analysis. 
2.5.3 Lipid peroxidation 
We evaluated the susceptibility of liver, brain, lung tissues to lipid peroxidation, induced by ROS acting upon 
polyunsaturated fatty acids, by using a TBARS assay to measure Malondialdehyde (MDA) levels. Homogenized 
tissues were centrifuged and supernatant were assayed in triplicates. All assays were analyzed using a 
spectrophotometer at 530-540 nm. The results were expressed as MDA (µM)/g of tissue.  
2.5.4 Mitochondrial DNA (mtDNA) integrity analysis  
Quantitative Polymerase Chain Reaction (QPCR) was used to determine the extent of mitochondrial damage. 
The rationale of the QPCR technique for quantitation of DNA damage is based on the ability of certain DNA 
lesions to disrupt the progression of the thermostable polymerase on the DNA template, resulting in a decrease 
of template amplification.  To measure the relative amplification levels and the frequency of lesions in our 
samples, we selected two amplicons:  a long amplicon (10kB) and a short amplicon (117bp). The long amplicon 
products are more susceptible to have a lesion that stops the thermostable DNA polymerase and only those 
DNA template not containing DNA lesions will amplify. Small amplicon products were relatively insensitive to 
DNA damage, which serves as an internal control. The amplification of both fragments was conducted using 
mitochondrial gene-specific primers.  The primer nucleotide sequences for the amplification of the 10 kB 
mtDNA amplicon were the following: 5’- CCACTCCATCCACCACCATC-3’ (forward, genomic position 
5733) and 5’- CCACAACACCCC CATTCCTC-3’ (reverse, genomic position 15733). For the short amplicon 
(117bp) the primer nucleotide sequences were: 5’- CCCAGCTACCATCATTCA-3’ (forward, genomic position 
13603) and 5’- AGTGATGGTTTGGGATGGTTGATGT-3’ (reverse, genomic position 13719). The validation 
for the mtDNA analysis consisted in the optimization for the PCR profile and characterization of the amplicons 
of interest for liver and brain tissues. To guarantee that the amplification rate was at the exponential phase, 
during each set of amplifications, a 50% (internal quality control) parameter was included containing half of the 
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amount of the non-damage template, which yielded a 50% reduction of the amplification signal.  
2.5.4.1 DNA isolation and DNA quality assessment 
DNA isolation was performed using the High Molecular Weight DNA Isolation kit, Qiagen Genomic Tip 20/G 
and Qiagen DNA Buffer according to the manufacturer's instructions. DNA from liver and brain tissues 
homogenates were isolated for downstream analysis (PCR). Quality control was performed using a Nanodrop 
spectrophotometer (NanoDrop 2000, Thermo Fisher) with the following quality parameters (A260/280=1.9).  
2.5.4.2 Characterization of amplicons 
In order to confirm the amplicons integrity, two electrophoresis gels were run independently, according to their 
respective length. A 3% agarose gel was run for the small amplicon (117 bp) at 100V for 20 mins and a 0.8% 
agarose gel was run for the large amplicon (10 KB) at 100V for 1 hr. TAE (1X) buffer was used for running 
electrophoresis gels. Two ladders were used to characterize the small and large fragments, 50 bp DNA ladder 
(Novagen) and a 1 Kb ladder (Promega). An amount of 10 µL of PCR product and 3 µL of loading dye were 
used when running the agarose gels.  
2.5.4.3 PCR conditions  
For amplification of long and small segment a total of 5 µL DNA template was used for a total concentration of 
20 µg/µL in a final volume of 50 µL. The 50% (internal quality control) amplification sample consisted of 5 µL 
DNA template was used for a total concentration of 10 µg/µL in a final volume of 50µL. The mtDNA damage 
was detected in liver and brain tissues by the GeneAmp® High Fidelity PCR system (Applied Biosystems).  
mtDNA specific primers were purchased from Integrated DNA Technology, Inc. (IDT) for each one of the 
amplicons. The Bio-Rad PCR thermal cycler was used to provide the specific thermal conditions for the study. 
Thermal cycles were determined to keep the reaction in the exponential phase of the PCR.  The PCR thermal 
program for the amplification of 117 bp mtDNA fragment consisted of an initial denaturation for 1 min at 94°C, 
followed by 17 cycles of denaturation for 15 sec at 94°C, annealing/extension at 60°C for 12 min and a final 
extension at 72°C for 10 min. The same parameters were used for the amplification of 10 kB mtDNA fragment 
with a change in annealing/extension step consisting of 67°C for 12 min.  
2.5.4.4 Fluorometric dsDNA quantitation assay 
dsDNA PCR products were quantified by measuring  the DNA fluorescence ( RFU). The assay was performed 
according to the manufacturer instructions (Quant-iT PicoGreen® dsDNA Assay Kit, Invitrogen).  To improve 
sensitivity of the lecture, black solid 96-well microplates (Corning Life Sciences) and fluorescence was 
determined by the BioTek Synergy HT at 485 nm (20 nm bandwidth excitation filter) and a 528 nm (20 nm 
bandwidth emission filter). Raw Fluoresence Units (RFU) values were used to calculate the relative 
amplification levels and the Poisson equation for frequency of lesions.   
2.6 Detection of 8-oxodeoxyguanosine (8-OHdG) levels 
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We measured levels of 8-oxodeoxyguanosine to quantify DNA oxidation due to oxidative stress damage using 
DNA extracted from liver and brain tissues. The extracted DNA was digested into ssDNA by incubating the 
samples at 95°C for 5 mins followed by incubation on ice. The DNA denaturalization was performed with 5-20 
units of nuclease P1 (Sigma Aldrich) for 2 hrs at 37°C in 20mM Sodium Acetate solution (pH 5.2). In addition, 
a total of 5-10 units of alkaline phosphatase (Cell Biolab) were added for 1 hr at 37°C at 100mM (pH 7.5). Final 
reaction mixture was centrifuged for 5 mins at 6,000 x g and supernatant was used for the Oxiselect TM 
Oxidative DNA damage ELISA (Cell Biolab) to determine the extent of the oxidized DNA nucleoside, an 
ubiquitous oxidative stress marker. All experimental samples were read at 450 nm using a microplate reader 
(Life technologies). The standards and experimental samples were performed in duplicate and the final results 
were expressed as 8-OH-dG levels (µg/mL). 
3. Results 
 
Figure 1: Antioxidant capacity in term of Trolox (mM) equivalent units in mice serum. Bars represent mean 
±1.96 (SD) with distribution of samples per group in scatter blot column. Interval of confidence at 95% were as 
follow: Control: 2.54+/-1.96 (0.40), NAC: 1.74 +/- 1.96 (0.31), PQ: 1.71 +/- 1.96 (0.30), and PQ+NAC: 2.32 +/- 
1.96 (0.34). The sample size of the experimental groups was as follow: Control (N=5), NAC (N=6), PQ (N=7), 
and PQ+NAC (N=7). 
Typically, low molecular weight molecules with high antioxidant capacity are transported in the serum to 
counteract oxidative stress. Such molecules are glutathione, ascorbic acid, uric acid, tocopherols, carotenoids, 
bilirubin, and amino acids such as methionine and cysteine. The total effect exerted by these molecules serves as 
a common indicator of the progression of oxidative stress. Under our experimental conditions, we aimed to 
determine the effects of NAC against PQ-induced oxidative stress in mice serum.  Mice serum collected from 
our experimental groups were submitted to the quantification of the antioxidant capacity levels in order to 
screen if PQ decrease the antioxidant capacity levels and what effect NAC supplementation would have. As 
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depicted in Fig. 1, One-way ANOVA showed no significant differences in the distribution of the antioxidant 
capacity levels among the experimental groups (p= 0.20). Our results suggested that neither PQ nor NAC 
modulate the antioxidant capacity levels in mice serum.  
 
 
 
 
 
 
 
Figure 2: Glutathione (GSH) levels (µM) of (A) liver, (B) brain and (C) lung tissue of mice. Bars represent 
mean ±1.96 (SD) with distribution of samples per group in scatter blot column. (A) Interval of confidence at 
95% were as follow: Control: 5.40+/-1.96 (0.42), NAC: 4.66 +/- 1.96 (0.43), PQ: 1.82 +/- 1.96 (0.40), and 
PQ+NAC: 3.34 +/- 1.96 (0.55). The sample size of the experimental groups was as follow: Control (N=6), NAC 
(N=7), PQ (N=5), and PQ+NAC (N=6). (B) Interval of confidence at 95% were as follow: Control: 22.50 +/-
1.96 (0.80), NAC: 35.03 +/- 1.96 (1.35), PQ: 10.86 +/- 1.96 (1.24), and PQ+NAC: 23.01 +/- 1.96 (1.52). The 
sample size of the experimental groups was as follow: Control (N=4), NAC (N=5), PQ (N=6), and PQ+NAC 
(N=5). (C) Interval of confidence at 95% were as follow: Control: 0.09 +/-1.96 (0.19), NAC: 1.60 +/- 1.96 
(0.30), PQ: 0 +/- 1.96 (0) and PQ+NAC: 2.92 +/- 1.96 (0.56). The sample size of the experimental groups was 
as follow: Control (N=6), NAC (N=7), PQ (N=7), and PQ+NAC (N=7). 
NAC is a precursor of one of the most versatile antioxidant, glutathione. GSH levels were analyzed to determine 
to what extent ROS due to oxidative stress induced by PQ interferes with GSH levels and the effect of NAC on 
GSH levels. Results are depicted in Fig. 2 (A, B, C).  As shown in Fig. 2A, One- way ANOVA analysis was 
performed showing strongly significant differences among the experimental groups (**p=0.001). Multiple 
comparison analysis by Tukey test (post-hoc) showed statistical significance among the experimental groups 
(Control vs. PQ, NAC vs. PQ). As expected in liver tissue at Fig. 2A, PQ induced oxidative stress reduced the 
amount of GSH in comparison with the control group. NAC appears to provide a partial protective effect when 
administered simultaneously to PQ. The effect of NAC administered to PQ and PQ+NAC mice, did not reach 
statistical significance, but nonetheless showed an expected tendency. GSH levels in brain tissue of treated mice 
are depicted in Fig. 2B. One- way ANOVA analysis was performed showing significant differences among the 
experimental groups (**p=0.04). Multiple comparison analysis by Tukey test (post- hoc) showed statistical 
significance among the experimental groups (NAC vs. PQ). PQ treatment reduced total GSH levels while NAC 
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supplementation increased total GSH levels in comparison with the Control group. When both drugs were 
together (PQ+NAC) they showed an intermediate profile indicating that NAC was capable of offsetting the 
oxidative stress damage induced by PQ. Likewise, the GSH levels in lung tissue are depicted in Fig. 2C. Given 
the variable nature and composition of lung tissue our data showed a non significant trend. One-way ANOVA 
analysis showed no significant differences (p=0.14) among the experimental groups. Each tissue displayed a 
unique profile of GSH levels, but the three tissues confirmed that NAC alone and even in presence of PQ 
partially restored the GSH synthesis. However, these observations were more prominent in liver and lung tissues 
due to the fact that both tissues were involved in the main principal site of action of NAC and PQ. 
 
 
 
 
 
 
 
Figure 3: Lipid peroxidation (MDA) levels of (A) liver, (B) brain and (C) lung tissue of mice. Bars represent 
mean ±1.96 (SD) with distribution of samples per group in scatter blot column. (A) Interval of confidence at 
95% were as follow: Control: 11.02+/-1.96 (0.47), NAC: 12.92 +/- 1.96 (0.66), PQ: 16.77 +/- 1.96 (0.64), and 
PQ+NAC: 14.69 +/- 1.96 (0.78). The sample size of the experimental groups was as follow: Control (N=6), 
NAC (N=7), PQ (N=7), and PQ+NAC (N=7). (B) Interval of confidence at 95% were as follow: Control: 
6.33+/-1.96 (0.33), NAC: 13.28 +/- 1.96 (0.71), PQ: 11.58 +/- 1.96 (0.59), and PQ+NAC: 14.47 +/- 1.96 (0.84). 
The sample size of the experimental groups was as follow: Control (N=6), NAC (N=7), PQ (N=7), and 
PQ+NAC (N=6). (C) Interval of confidence at 95% were as follow: Control: 23.31+/-1.96 (1.18), NAC: 22.93 
+/- 1.96 (1.18), PQ: 21.46 +/- 1.96 (1.01), and PQ+NAC: 22.42 +/- 1.96 (0.91). The sample size of the 
experimental groups was as follow: Control (N=6), NAC (N=7), PQ (N=7), and PQ+NAC (N=7). 
Lipid peroxidation is a well-established oxidative stress biomarker. We determined if PQ-induced oxidative 
stress increases the MDA levels and how the antioxidant effects of NAC would affect lipid peroxidation. The 
MDA levels are depicted in Fig. 3 (A, B, C). One- way ANOVA analysis showed significant differences among 
the experimental groups (*p<0.02). Multiple comparison analysis by Tukey test (post- hoc) showed statistical 
significance among the experimental groups (Control vs. PQ, PQ vs. PQ+NAC). As depicted in Fig. 3A, PQ-
induced oxidative stress by a significant increase in the MDA levels compared to the control group. One- way 
ANOVA analysis showed strongly significant differences among the experimental groups (**p=0.001). 
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Multiple comparison analysis by Tukey test (post- hoc) showed statistical significance among the experimental 
groups (Control vs. NAC, Control vs. PQ, and Control vs. PQ+NAC). In Fig. 3B, a significant increase in MDA 
levels were observed in comparison with control group. We observed a nominal increase in MDA levels in NAC 
group. The MDA levels in lung tissue as depicted in Fig. 3C, shown no significant differences among the 
experimental groups (p=0.90) by One-way ANOVA analysis.  
 
Figure 4: Mitochondrial DNA damage (A) Relative amplification of mtDNA and (B) Poisson analysis for 
detection of lesions frequency in mtDNA both of liver and brain tissues of mice. Bars represent mean ±1.96 
(SD) with distribution of samples per group in scatter blot column. (A) Relative amplification for liver tissue- 
Interval of confidence at 95% were as follow: Control: 1+/-1.96(0), NAC: 0.92 +/- 1.96 (0.10), PQ: 0.71 +/- 
1.96 (0.07), and PQ+NAC: 0.90 +/- 1.96 (0.09). The sample size of the experimental groups was as follow: 
Control (N=5), NAC (N=5), PQ (N=4), and PQ+NAC (N=5). Relative amplification for brain tissue- Interval of 
confidence at 95% were as follow: Control: 1+/-1.96(0), NAC: 0.95 +/- 1.96 (0.18), PQ: 0.63 +/- 1.96 (0.16), 
and PQ+NAC: 0.69 +/- 1.96 (0.15). The sample size of the experimental groups was as follow: Control (N=5), 
NAC (N=4), PQ (N=5), and PQ+NAC (N=5). (B) Poisson analysis for liver tissue- Interval of confidence at 
95% were as follow: NAC: 0.07 +/- 1.96 (0.10), PQ: 0.33 +/- 1.96 (0.08), and PQ+NAC: 0.07 +/- 1.96 (0.10). 
The sample size of the experimental groups was as follow: NAC (N=5), PQ (N=4), and PQ+NAC (N=5).  
Poisson analysis for brain tissue- Interval of confidence at 95% were as follow: NAC: 0.11 +/- 1.96 (0.14), PQ: 
0.47 +/- 1.96 (0.20), and PQ+NAC: 0.30 +/- 1.96 (0.16). The sample size of the experimental groups was as 
follow: NAC (N=4), PQ (N=5), and PQ+NAC (N=4). 
One of the principal causes of mtDNA damage is the excess ROS generation in the inner membrane of the 
mitochondria due to the ETC. Given the proximity of the mtDNA to the ETC, it is more prone to DNA damage 
in comparison with the nDNA. We examined the mtDNA integrity to determine if NAC reduces the PQ-induced 
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oxidative damage of mtDNA. ROS induce a number of different lesions in the DNA, but under our experimental 
conditions we aimed to amplify the overall damage contained in two specific mtDNA amplicons: small 
amplicon (117 bp) and long amplicon (10 Kb). The small amplicon served as an internal control to normalize 
the mtDNA copy number due to the low sensitivity to DNA damage, while the long amplicon has a higher 
probability of being attacked by ROS resulting in a higher sensitivity for DNA damage. This method involved 
the isolation of DNA from tissues treated under the identical conditions of drug treatments followed by the 
screening of the relative amplification levels and frequency of lesions in liver and brain tissue by PCR. We 
measured the relative amplification of the mtDNA, which is inversely proportional to the DNA damage. Also, 
we analyzed the frequency of lesions with the Poisson equation analysis (Damage= -Ln Abs damage/ Abs no 
damage).  
As depicted in Fig.  4A, our data showed that mice with no treatment (control) showed the highest level of 
relative amplification (1.0), suggesting that mtDNA genome did not carried any lesion that delays the 
progression of the DNA polymerase activity. Also, One- way ANOVA analysis was performed showing 
strongly significant differences among the experimental groups (****p<0.0001) in liver tissue.  Multiple 
comparison analysis by Tukey test (post- hoc) showed statistical significance among the experimental groups 
(Control vs. NAC, Control vs. PQ, PQ vs. PQ+NAC, and NAC vs. PQ). Our results showed that PQ induced 
oxidative stress decreases the relative amplification levels of mtDNA and NAC reestablished these levels even 
comparable to the basal system. Also, as depicted in Fig. 4A, One- way ANOVA analysis showed strongly 
significant differences among the experimental groups (****p<0.0001) in brain tissues. Multiple comparison 
analysis by Tukey test (post- hoc) showed statistical significance among the experimental groups (Control vs. 
PQ, NAC vs. PQ, NAC vs. PQ+NAC). Both relative amplification levels in liver and brain tissue showed 
statistically significant differences.   
As shown in Fig. 4B, we confirmed that frequency of lesions was inversely proportional of the DNA damage in 
liver and brain tissue. Specifically, One- way ANOVA analysis showed strongly significant differences among 
the experimental groups (****p<0.001) in liver tissue.  Multiple comparison analysis by Tukey test (post- hoc) 
showed statistical significance among the experimental groups (NAC vs. PQ and PQ vs. PQ+NAC). In brain 
tissue, One- way ANOVA showed strongly significant differences among the experimental groups (**p<0.02). 
Multiple comparison analysis by Tukey test showed statistical significance among the experimental groups 
(NAC vs. PQ). The results depicted in Fig. 4B were consistent and representative with the relative amplification 
levels obtained in Fig. 4A. Also, as depicted in Fig. 4A, an internal parameter (50%) was used to confirm that 
our results were in the exponential phase (40% - 60%). In both tissues this parameter was achieved, as expressed 
in liver tissue with 60% and in brain tissue with a 52%.  
The current paradigm states that ROS and oxidative stress cause mutations in DNA. We wanted to test this 
paradigm by quantifying the levels of 8-OH-dG in DNA extracted from liver and brain tissue from our 
experimental groups. 8-OH-dG is the oxidized form of deoxyguanosine found in DNA and is a well-established 
indicator of DNA damage due to oxidative stress. Levels of 8-OH-dG are an important biomarker for the 
activity of ROS. As depicted in Fig. 5A, One- way ANOVA analysis showed strongly significant differences 
among the experimental groups (*p<0.003). Multiple comparison analysis by Tukey test (post- hoc) showed 
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statistical significance among the experimental groups (PQ vs. PQ+NAC). Our results showed that PQ induced 
oxidative stress by increasing the 8-OH-dG levels in liver tissue. NAC treatment might replenish GSH levels 
and maintains the background level of 8-OH-dG as depicted in the control group. Besides, the effect of NAC in 
presence of PQ reduces statistically significant the 8-OH-dG levels in liver tissue even to lower levels of the 
basal system. In addition, as depicted in Fig. 5B, One- way ANOVA analysis showed significant differences 
among the experimental groups (p= 0.20). In brain tissue, NAC did not decrease 8-OH-dG levels. For instance, 
a similar distribution of 8-OH-dG levels was observed among the four experimental groups. 
 
Figure 5: The levels of oxidized DNA base 8-oxodeoxyguanosine (8-OHdG) in (A) liver and (B) brain tissues 
of mice. Bars represent mean ±1.96 (SD) with distribution of samples per group in scatter blot column. (A) 
Interval of confidence at 95% was as follow: Control: 1.15+/-1.96 (0.30), NAC: 1.02 +/- 1.96 (0.19), PQ: 1.46 
+/- 1.96 (0.19), and PQ+NAC: 0.85 +/- 1.96 (0.22). The sample size of the experimental groups was as follow: 
Control (N=5), NAC (N=5), PQ (N=5), and PQ+NAC (N=4). (B) Interval of confidence at 95% were as follow: 
Control: 1.50+/-1.96 (0.31), NAC: 1.33 +/- 1.96 (0.20), PQ: 1.82 +/- 1.96 (0.34), and PQ+NAC: 1.37 +/- 1.96 
(0.25). The sample size of the experimental groups was as follow: Control (N=4), NAC (N=5), PQ (N=4), and 
PQ+NAC (N=4). 
4. Conclusion 
Present study investigated the PQ-induced oxidative stress in vital body tissues and the counteractive effect of 
NAC by evaluating the serum antioxidant capacity, lipid peroxidation, antioxidant GSH levels, and DNA 
integrity and damage in mice. The authors in [3, 36, 57] noticed that the homeostatic control of antioxidant 
capacity in blood and other tissues has been extensively studied including how this capacity is modified during 
the oxidative stress process. Our data suggest that under the experimental conditions neither PQ nor NAC 
modulated the mice serum antioxidant capacity. We speculated that both PQ and NAC displayed a limited 
potential in serum due to several reasons involving short half-lives, fast metabolic degradation, and the 
pharmacokinetics of the drugs. For example, NAC is metabolized very fast and has a low toxicity profile by oral 
International Journal of Sciences: Basic and Applied Research (IJSBAR) (2016) Volume 26, No  1, pp 26-46 
38 
 
administration with a half-life of 5.0 - 6.25 hrs [2]. As the results in [32, 68] indicated that NAC has <5% 
bioavailability after passing through N-deacelytation in the intestinal mucosa followed by the first pass 
metabolism in the liver tissue. Moreover NAC does not accumulate in blood or tissues and it is rapidly excreted 
by the renal system (30%) and by non-renal system (70%) [72]. On the other hand, PQ shows a high toxicity 
profile whether by oral ingestion or by intraperitoneal administration but it is not well absorbed from the 
gastrointestinal tract [30]. PQ is mainly distributed to lung, liver, kidneys and lastly plasma [11, 76]. Most 
importantly, PQ is poorly metabolized (<5%) and 64% is excreted in 1 hour as the parental compound in feces 
and urine.  
Based on the pharmacokinetics, we speculated that short half lives of ROS induced by PQ were scavenged 
quickly in the serum exerted a limited oxidant effects, which in turn makes a weak signal to be target by 
antioxidant defense system. We also believe that the transitory effects exerted by PQ and NAC during the 3- 
weeks treatment needs to be optimized so as to determine the window for sample collection [39, 78].  Another 
possible reason is that our rodent model (Balb/C mice) has neither genetic modifications nor oxidative stress 
enzymes deficiencies. Our data suggest that present rodent model has a robust REDOX response and was able to 
overcome oxidative stress response induced by PQ without supplementation of the exogenous antioxidant NAC. 
This is in agreement with the data reported in rodent models by authors in [8, 45, 81] which evidenced that the 
baseline levels for antioxidant capacity fluctuate from 0.7 - 2.50 mM equivalents of Trolox. Our data are in 
agreement with these finding because our control mice showed an antioxidant capacity of 2.54 mM units 
equivalents of Trolox. With these findings, we predict that mice with lower antioxidant capacity levels would be 
unlikely to overcome the oxidative stress response and mice with a higher antioxidant capacity would be likely 
to overcome these responses [42]. 
In line with these data, we might correlate the antioxidant capacity with the response of the GSH metabolism in 
mice exposed to PQ and NAC. The authors in [49, 50] showed that the distribution of GSH levels might vary 
depending on the specific requirements and physiological functions in the specific organs or tissues of mice. 
Our data showed significant differences of GSH levels in liver and brain tissues, but not in lung tissue. For 
example, in liver tissue we observed as expected the GSH depletion induced by PQ and the boost of GSH 
induced by NAC. GSH enriched levels in liver tissue explained the expected result of total GSH levels, 
specifically in NAC group. This is because GSH concentration in cytosol ranges from 1-10 mM , but in 
hepatocytes the concentration is high as 10 mM due to hepatocytes active transport of GSH to the rest of the 
blood and tissues [29, 53]. In concordance with our data, author in [14] showed that both PQ and Diquat 
subcutaneous dose at 130 mg/kg between 0.5 hrs and 4 hrs interferes with GSH recycling mechanisms inducing 
subsequently GSH depletion in liver tissue and biliary duct of male CD-1 mice. Indeed, we did not measure the 
oxidized glutathione (GSSG)/ reduced glutathione (GSH) ratio, we predict that this balance will provide more 
insight of the potential indicators of hepatic oxidative stress caused by PQ.  
Our data further showed that mice exposed to only NAC presented the highest GSH levels in comparison with 
the other groups, suggesting that NAC reached the brain tissue. This is in agreement with previous studies 
conducted by authors in [4, 25] in the central nervous system. As the result in [70], NAC impact the modulation 
of the antioxidant defenses against oxidative damage as a result of ROS scavenge in the dopaminergic system of 
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neuronal cells. As expected, GSH depletion by PQ exposure is a direct consequence of repeated PQ doses 
administrations that get accumulate into the brain tissue eliciting neurotoxicity as reported by authors in [30, 
52]. PQ modulates REDOX regimen showing a reduction of GSH levels and increase in the oxidized 
glutathione GSSG [39]. There were no significant differences of GSH levels among the experimental groups in 
lung tissue, which is the main site action by PQ. However a trend in the effects induced by either NAC or PQ 
was observed in the lung tissue of mice. The authors in [1, 64] have demonstrated that GSH content in lung 
decreases in the presence of thiol depleter as PQ due to the destruction of alveolar type II cells. Also, 
supplementation of antioxidants such as NAC over prolonged period resulted in an elevation of intracellular 
GSH pool and decreased the susceptibility of tissue to oxidant-induced tissue injury and delayed the lung tissue 
inflammation [20]. Depletion of GSH levels prone the membrane lipids to severe oxidative damage. The 
correlation of the former conditions with lipid peroxidation (MDA levels) was an indicator of the ongoing 
oxidative stress process in the tissues that have been under studied. Present data showed significant differences 
in the MDA levels among the experimental groups in liver and brain tissues, but not in lung tissue.  
Furthermore liver tissue was more likely to undergo oxidative lipid peroxidation than the other tissues due to the 
high amount of lipid composition and rates of detoxification [60]. In agreement with study reported by author in 
[59], it was showed that mice hepatocytes that were treated with PQ showed higher cytotoxicity and MDA 
levels. Hepatocytes are sensitive to quinones as PQ treatment due to their low glutathione content, which in turn 
makes them more prone to lipid peroxidation. Hepatocytes are the major inducer of GSH synthesis as observed 
in mice undergoing NAC supplementation in comparison with the rest of the experimental groups. Data further 
showed significant differences of MDA levels among the experimental groups in brain tissue. However, our 
results showed a tendency of NAC as a pro-oxidant agent not prominently noted in the literature. There are few 
studies that reported the exerting action of NAC as a pro-oxidant. Our findings are in agreement with the 
proposed mechanism of thyl radicals as a consequence of the interaction of PQ with steady state levels of 
superoxide. The basic mechanism of action of thiols is to scavenge the hydroxyl and superoxide radicals. When 
thiol groups interact with the former radicals they form a potent thyl radical [13]. Thyl radical reacts with free 
fatty acids, as those found in brain tissues, and forms potent peroxyl radicals [69]. Therefore, it is suggested that 
thyl radicals act as a strong oxidant that interferes with GHS metabolism and at the same time increasing the 
peroxidation of neuronal biological membranes [77]. We observed that PQ induced less lipid peroxidation than 
NAC, yet PQ in the presence of NAC showed similar rates of lipid peroxidation as NAC group, confirming the 
effect of NAC as a pro-oxidant. It is supported by our data on GSH levels that NAC group showed the highest 
concentration of GSH levels compared to other experimental groups. On the other hand, we expected to detect 
higher MDA levels in mice lung tissue after PQ exposure since its toxicity have been often used by authors in 
[38, 80] to create models for acute lung injury and pulmonary fibrosis. However, our data showed no significant 
differences in the MDA levels among the experimental and control group. The possible reason is that lung tissue 
contained high levels of oxidative stress background due to the high composition of lipids that surround the 
alveolar cells accustomed to an oxidant rich environment. Earlier study has also reported that prolonged PQ 
treatment resulted in a continual slow rate of lipid peroxidation and a slow rate of antioxidant defenses 
replenishment in lungs [24]. Based on the fact that even though lipid peroxidation predicts the levels of 
oxidative membrane damage, MDA levels are not an absolute indicator of lipid peroxidation because of its rapid 
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degradation in vivo models [7]. 
Our study further investigated the extent of oxidative genomic damage in mice exposed to PQ and amelioration 
by NAC measured by PCR and ELISA assays which are highly sensitive and specific for detecting genomic 
damage in mtDNA and nuclear DNA ( nDNA, 8-OH-dG). The authors in [22, 37, 48, 74, 82] have reported that 
mtDNA is a sensitive biomarker for oxidative damage due to lacks of DNA protecting histones, has limited 
DNA repairing mechanisms, and its close proximity to the electron transport chain (ETC). Studies reported by 
authors in [16, 82] showed for the first time the incorporation of PCR with the purpose of screening the effects 
of a variety of genotoxicant agents in the relative amplification and frequency of lesions in the mtDNA of mice, 
rats, human, rhesus monkeys, and yeast models. However, we are the first one to report the effects of PQ and 
NAC in mtDNA amplification and frequency of lesions in a rodent model by this technique. Both liver and 
brain tissues showed strong significant differences (p <0.0001) in relation to amplification levels and frequency 
of lesions among the experimental groups due of the high susceptibility of mtDNA to oxidative damage. One of 
the earlier study conducted by author in [26] have shown that PQ exacerbates the generation of ROS in the 
mitochondria, subsequently inhibiting the normal function of complex I and IV, leading to the reduction of ATP 
synthesis, genome instability and ultimately cell death.  Most reports showed a decrease in the complex 1 and to 
a lesser extent in complex IV, while complex II and III are mostly unaffected [21]. Due to the fact that complex 
I and IV are encoded by mtDNA whereas complex II and III are encoded by nDNA, it was expected to detect a 
greater presence of mtDNA levels in liver and brain tissues [66]. Subsequently, the amount of mtDNA damage 
represents an early indicator of liver and brain mitochondrial dysfunction which was ameliorated by thiols that 
increased the flow of the ETC by substituting reducing equivalents whom may be absent in the ETC [16, 44, 47, 
48, 55]. Therefore, we speculate the effects of NAC in restoring the amplification levels of mtDNA as reducing 
equivalents improved the energy status, restored the genome stability because it acts as a scavenger of ROS over 
the rate of ROS generation induce by PQ exposure. 
As the results indicated in [41, 46], guanine is the main target of ROS and its oxidized form, 8-OH-dG levels, is 
the most frequent base lesion in nDNA which make it an ubiquitous biomarker to provide information of 
ongoing oxidative stress in the system. As expected, our data showed significant differences among the 
experimental groups in liver tissue. PQ significantly induced oxidative damage to nDNA, while according to 
previous studies NAC exerted its effects through a non-enzymatic mechanism in the regulation of cellular redox 
homeostasis, enhancing intracellular biosynthesis of GSH, and ROS scavenging activity [56, 83]. These findings 
were confirmed by an earlier study conducted by author in [65], which showed how NAC decreased 8-OH-dG 
levels as close as in the wild type in ATM deficient rodent model (C57bl6J/p). The modulating effects of NAC 
can be seen in a rodent model lacking genes to cope with oxidative stress and in our Balb/C rodent model that 
also have no genetic modification. The levels of 8-OH-dG in brain tissue did not show significant differences 
among the experimental groups. Our data showed a similar distribution of 8-OH-dG levels suggesting that 
nDNA has a greater capacity of DNA repair mechanism to detect 8-OH-dG lesions from the system more 
efficiently. Our results are in agreement with a previous report [40]. that brain tissue has intracellular 
antioxidant defenses, which are highly competent. Usually, the terminals of the neuronal cells need high levels 
of ascorbic acid, in which GSH is required for their modulation and for maintaining ascorbic acid in it reduced 
form. We speculated that mice undergoing NAC treatment were more likely to modulate the levels of GSH, 
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which subsequently modulates the ascorbic acid for a better antioxidant response. Therefore, our results 
suggested that PQ effect was more evident in liver tissue by inducing 8-oxo lesions showing more susceptibility 
to nuclear DNA damage rather than in brain tissue, which showed less susceptibility to nDNA damage. In 
conclusion, taking together these results demonstrated that Paraquat induced oxidative stress response by 
inducing hepatic membrane lipid peroxidation, hepatic oxidative nDNA damage, liver and brain mtDNA 
damage as well as by depleting liver, brain and lung GSH levels in mice. Treatment with antioxidant (NAC) 
ameliorated oxidative stress response in the liver of mice. These results have important implications in the 
future as in the use of a non-invasive and cost effective therapy as a reliable reducing agent of oxidative stress 
effects mediated by PQ.  
We considered the following future steps in order to extend this project into a new research phase in order to 
overcome few limitation of the study. In the antioxidant capacity test, due to the multivariable nature of redox 
status, we are considering to conduct a battery of tests in mice serum that include dose-dependent studies in 
order to determine the pharmacological trend and the peak value of PQ and NAC. Also, the total GSH levels 
that were measured in our study included the amount of reduced GSH and oxidized GSSG levels per tissue. We 
could not explore the individual levels of GSSG and establish a ratio in respect of GSH levels. Therefore, the 
further steps would be to proceed with the GSSG derivatization. In regards to the lipid peroxidation analysis, we 
would complement this analysis with the glutathione peroxidase (GP) studies in order to compare the reduced 
hydroperoxides to the corresponding alcohols and to reduce free hydrogen peroxide to water with MDA levels. 
DNA integrity analysis conducted by PCR was one of the most sensitive analyses that we perform in this 
research study. Even though the results obtained were the expected, it will be interestingly to extend this assay 
by exploring the possible effect of the genotoxicity of PQ and antioxidant activity of NAC but including the 
nDNA. The selection of specific primers in nDNA of the analogous segments that were used in the mtDNA can 
be used to compare the degree of damage or repair in nDNA vs. mtDNA in the same biological sample. In this 
way, we would be able to compare the rates of damage in mtDNA and nDNA under the same experimental 
conditions. Lastly, we would suggest to include in a future experimental design another tissue or biological 
source to screen for 8-oxo levels, as for example mice urine. The major route of excretion of ubiquitous 
oxidative stress lesions, such as 8-oxo, is by body fluid excretion.  
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